Two human papillomavirus (HPV)-negative epithelial cell lines, HaCaT and C33A, were transfected with HPV-16 E6 and analysed for functional consequences which are relevant to invasive tumour progression. After transfection with E6, both cell lines invaded collagen matrices, in contrast to vector-transfected control cells. The E6-expressing cells showed a marked increase in expression of the β1 integrin subunit, with no or relatively minor alterations in the levels of a range of integrin subunits. In addition, the epithelial cell lines expressing E6 displayed resistance to apoptosis generated by serum starvation. This resistance is comparable to that generated by ras and is not generated by HPV-11 E6 or HPV-16 E7. Both C33A and HaCaT cells have mutations in the p53 loci and hence these functional consequences of E6 are probably independent of wild-type p53 function.
In this report, we have explored the phenotypic consequences of E6 expression per se in epithelial cell lines. In general, transformed cells are generated following the cumulative effects of changes in apoptosis induction, cell cycle control, motility, integrin expression and function. These processes are linked in intricate feedback loops and the deregulation of the feedback controls during tumorigenesis is currently under investigation by several groups (Meredith & Schwartz, 1997 ; Schwartz, 1997) . In this report, we have focused on an analysis of the role of the HPV-16 E6 oncogene in altering motility, integrin patterns and generating resistance to apoptosis induction in human epithelial cell lines.
We have used two HPV-negative cell lines, C33A (Crook et al., 1991) , a cervical tumour-derived cell line, and HaCaT (Lehman et al., 1993) , a spontaneously immortalized epithelial line. Using plasmid LXSN-16E6 (Etscheid et al., 1994) , we generated HaCaT-E6 and C33A-E6, which are HaCaT and C33A cells that constitutively express HPV-16 E6. Our approach using pooled transfectants is similar to that used in a recent study undertaken to analyse the role of cdc42 and Rac1 in integrin-mediated cell motility and invasiveness through PI(3)K (Keely et al., 1997) . LXSN-neomycin-expressing cells, i.e. HaCaT-Neo and C33A-Neo, were used as controls in all experiments.
HaCaT-E6 and C33A-E6 cells (1500 cells per well) were seeded on polymerized collagen and immersed in cell culture media (DMEM with 10 % FCS) for 10 days. Both HaCaT-E6 (Fig. 1 a, c) and C33A-E6 ( Fig. 1 b, d ) cells invaded the collagen matrices to around 2 cm, in contrast to HaCaT-Neo (Fig. 1 a,  c ) and C33A-Neo ( Fig. 1 b, d ) cells which displayed minimal invasion. Fig. 1 (e) demonstrates the expression of E6 transcripts in HaCaT-E6 and C33A-E6 cells as determined by Northern blots. When compared to C33A, CaSki cells invaded the collagen matrix (data not shown).
With a well-established link between alteration in β1 integrin subunit expression and function with changes in motility and tumorigenesis (Fishman & Hatten, 1993 ; Juliano, 1993 ; Keely et al., 1998 ; Sheetz et al., 1998) , we assessed the level of this protein in the E6-expressing cells (Fig. 2 a, b) . We found a consistent increase in the level of the β1 integrin subunit in both HaCaT-E6 (Fig. 2 a) and C33A-E6 (Fig. 2 b) cells compared to HaCaT-Neo (Fig. 2 a) and C33A-Neo (Fig. 2 b) 0001-6055 # 1999 SGM Motility assay using collagen matrices. LXSN-Neo and LXSN-16 E6 plasmids were transfected in C33A and HaCaT cells using the transfection reagent LipofectAmine (Gibco BRL). Cells were selected by growing them in medium containing 1n8 mg/ml G418 (Gibco BRL) for over 15 days. Neomycin-resistant colonies were pooled and used for all the assays described. In contrast to control Neo cells, E6-expressing (a) HaCaT and (b) C33A cells show striking differences in motility. For growth on collagen matrices, 75 % (v/v) Type I collagen (Vitrinogen-100) was polymerized for 8 h in DMEM (20 % FCS) using 5 µl 1 M NaOH in 96-well microtitre plates. Epithelial cells were seeded (1500 cells per well) and the collagen plugs were left immersed in DMEM (10 % FCS) for 10 days. The plugs were subsequently fixed in 4 % paraformaldehyde for 7 min and cryosectioned. Cells were visualized under bright field to measure the invasion (a, b, left panels). Subsequently, the nuclei were visualized with Hoechst 33342 dye and photographed at i400 final magnification (a, b, right panels). A black dashed line represents the membrane where the cells were seeded. In all experiments, invasion was quantified using photomicrographs by typically counting a minimum of 25 cells in four experiments. (c and d) Quantitative representation of invasion of collagen matrices by the indicated cell lines. Photographs were scanned and processed using the Adobe photoshop version 4. (e) Northern blot analysis was performed with RNA prepared from the indicated cell lines according to standard protocols (Sambrook et al., 1989) . Equal quantities of total RNA were loaded in each lane. Since CaSki is known to have several hundred HPV genomes, 1 : 10 dilution of RNA was loaded in that lane.
cells. To assess whether cell surface expression of the β1 integrin subunit was a specific upregulation or a generalized alteration in the level of cell surface proteins, we examined the levels of a range of cell surface proteins. There was no alteration in the level of three integrin subunits that we examined (α1, α2 and αv) in C33A-E6 cells, whereas HaCaT cells expressing E6 showed a modest increase in the level of α2 integrins (Fig. 2 a) . Staining of the α2 integrin subunit has been demonstrated to be representative of the α1, α2 and αv results for C33A-E6 cells (Fig. 2 b) .
Integrin subunits have been linked to the ability of cells to generate resistance to apoptosis (Faraldo et al., 1998 ; Matter et al., 1998 ; Rozzo et al., 1997 ; Scatena et al., 1998) . We compared the ability of HaCaT-E6 cells to resist anchorage-independent induced apoptosis and found that HaCaT-E6 cells generate lower resistance to anchorage-independent induced apoptosis compared to HaCaT-Ras cells (data not shown). In contrast, both HaCaT-E6 and C33A-E6 cells show a marked resistance to serum starvation-induced apoptosis over 16 days, in comparison to HaCaT-Neo and C33A-Neo cells (Fig. 3 a, b ).
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HaCaT ( We compared the serum starvation resistance of HaCaT cells expressing HPV-16 E6 to those expressing HPV-11 E6, HPV-16 E7 and the ras oncogene and found that HPV-16 E6 generates resistance to serum starvation comparable to that generated by ras, whereas both HPV-11 E6 and HPV-16 E7 do not generate resistance to serum starvation-induced apoptosis (Fig. 3 c) . We also examined the cell cycle profiles of HaCaTNeo and HaCaT-E6 cells on days 6 and 12 following removal of serum (Fig. 3 d) . Consistent with the results obtained when assaying apoptotic nuclear morphology (Fig. 3 a, b) , a large proportion of HaCaT-Neo cells appeared to undergo apoptosis at days 6 and 12. In contrast, the HaCaT-E6 cells retain a profile consistent with a population of cells undergoing the normal cell cycle. Annexin V staining at day 6 post-serum starvation showed a twofold difference in positivity between HaCaTNeo and E6-expressing cells (Fig. 3 e) . Hoechst staining (Fig.  3 a) and annexin V staining revealed about 15 % apoptotic cells (Fig. 3 e) at day 6 post-serum starvation in HaCaT-Neo cells (in comparison to unstarved controls which showed about 3-4 % apoptotic cells by either probe). DNA analysis (Fig. 3 d) at the same time-point showed a greater number of HaCaT-Neo cells that were suggestive of apoptosis. All three approaches are consistent with HaCaT-E6 showing protection against serum starvation-induced apoptosis (when compared to controls which are in the same range as the Neo controls).
We also detected an increase in cyclin A but not in a range of other cyclins (data not shown) that we analysed in HaCaT-E6 cells. Fig. 3 ( f ) demonstrates the dramatically increased frequency ( 85 %) of cells expressing cyclin A in HaCaT-E6 cells (red staining). Cyclin A levels in HaCaT-E6 cells were also found to be noticeably increased compared to HaCaT-Neo cells by Western blotting (Fig. 3 g) .
There have been reports that expression of HPV-16 E6 prevents the differentiation of cells (Sherman & Schlegel, 1996) and this is a contributing feature to tumorigenicity. We tested HaCaT-E6 cells for their ability to differentiate and found that both HaCaT and HaCaT E6 cells will express cytokeratin markers of differentiation in response to differentiationinducing stimuli, TGF-β and Ca# + (data not shown).
It is somewhat surprising that, except for levels of spontaneous apoptosis in the presence of serum (Fig. 3 a) , the effects of HPV-16 E6 expression in HaCaT and C33A cells are similar. Apart from their differences in genomic background, these cells differ in that HaCaT cells are merely immortalized and can be transformed by the ras oncogene (Skobe et al., 1997 ;  A. Rangarajan and others, unpublished results), whereas C33A cells are derived from an invasive tumour. In addition, they represent two different stages of differentiation in that HaCaT cells express cytokeratin 14, a marker of basal keratinoctyes, and in contrast C33A cells resemble more differentiated keratinocytes in expressing cytokeratin 10 and not 14 (Tergaonkar et al., 1997) . Thus, the differentiation status of the cell per se does not seem to modulate the effects of E6 reported in this study. The only difference that we have found between these two cell populations following E6 expression is that asynchronous cultures of HaCaT-E6 express high levels of cyclin A and we did not find a similar cyclin A alteration in C33A-E6 cells. The effects of HPV-16 E6 on motility and integrin expression have not been explored in any previous reports. The levels of integrin subunits in vivo are likely to reflect the combined effects of the expression of the other papillomavirus genes, deregulated host gene expression due to mutations and the modulation of tumour gene expression by the surrounding matrix. In advanced invasive stage cervical tumours, we have previously reported low levels of β1 integrin subunit expression (Daniel et al., 1997) and thus, is it conceivable that this upregulation of β1 expression is relevant to the earlier stages of cervical tumour progression.
Several efforts have been made to characterize the role of high-risk HPV-E6 proteins in modulation of apoptosis induced by a variety of physical and chemical means (Yu et al., 1997 ; Thomas et al., 1996 ; Wahl et al., 1996 ; Xu et al., 1995) . A generalization that can be derived from several such reports is that E6 suppresses apoptosis induced by physical agents like gamma or ultraviolet rays (Rapp & Chen, 1998) . On the contrary, it appears that E6 accentuates apoptosis induced by chemical agents like cisplantin, taxol, mitomycin C or atractyloside (Rapp & Chen, 1998) . HPV-16 E6, by virtue of its ability to degrade p53, can counter E7-induced apoptosis in developing retinal cells (Pan & Griep, 1995) . We did not detect any increase in apoptosis per se in HaCaT cells expressing E7 either constitutively or in serum starvation conditions in this study (Fig. 3 c) .
One interesting feature of the E6-mediated block of E7-induced apoptosis is that it could function even in cells which were null for p53, suggesting that E6-mediated protection is both p53-dependent and -independent (Pan & Griep, 1995) .
construct of oncogenic ras-containing vHarvey ras codon 12 mutation in the pGV16 vector was used to generate the HaCaTRas cells. HPV-16 E6 (16E6)-mediated protection against serum starvation-induced apoptosis is comparable to that generated by ras in HaCaT cells and not to that generated by HPV-11 E6 or HPV-16 E7. (d ) Flow-cytometric analysis of HaCaT cells undergoing serum starvation-induced apoptosis. Cells were harvested and washed with 50 % FCS in PBS (without calcium and magnesium), fixed using cold ethanol and stored overnight at 4 mC. Cells were stained by resuspending them in a staining solution containing propidium iodide (50 µg/ml), RNase A (0n1 mg/ml), NP-40 (0n1 %) and tri-sodium citrate (0n1 %), and incubated for 20 min at 4 mC before analysis on the Becton-Dickinson flow cytometer (Cell Quest). Cell populations in the G1, S1 and G2jM phases are indicated. (e) Annexin V staining was performed using a kit from Trevigen. Cells were harvested and stained according to manufacturer's instructions. No propidium iodide was included during staining. Cells were analysed using the Becton-Dickinson flow cytometer (Cell Quest). White bars, E6 ; hatched bars, Neo. This Figure is representative of two experiments. ( f ) Cyclin A expression in HaCaT-Neo and HaCaT-E6 cells (i20 magnification). Immuno-stainings with primary antibodies (Santa-Cruz and gifts from N. Dyson, MGH Cancer Center) and detection was done as reported previously (Tergaonkar et al., 1997 ; Daniel et al., 1997) . Over 85 % HaCaT-E6 cells showed cyclin A positivity in a low-power field. Inset shows positively stained cells under higher magnification. (g) Western blot analysis of lysates prepared from HaCaT Neo and E6 cells. Lysate preparation, electrophoresis, transfer and probing was done according to routine protocols (Harlow & Lane, 1988) . Cyclin A antibody was used at 1 : 200 dilution. Apart from the 60 kDa cyclin A band, we consistently observed a nonspecific 66 kDa band due to the secondary antibody. Biotinylated secondary antibody (Vector Laboratories) and avidin-HRP (Bangalore Genei) were used according to manufacturers ' instructions. NBT, BCIP system (Boehringer Mannheim) was used for detection.
Other reports have also indicated that E6 can mediate its antiapoptotic activity in a p53-independent manner (Brown et al., 1997 ; Steller et al., 1996) . HaCaT (Lehman et al., 1993) and C33A (Crook et al., 1991) cells have mutations in the p53 loci and the resistance to serum starvation-induced apoptosis is likely to be mediated by a p53-independent pathway. However, given that these lines might make mutant forms of p53 proteins which functionally interact with E6, it is difficult to categorically rule out the possible role of p53 in the observed phenotypes. It is intriguing that HPV-11 E6 in this study was found not to generate resistance to apoptosis induced by serum starvation. A major difference between the low-and high-risk viruses has been in their ability to induce degradation of p53. However, if the resistance to serum starvation reported in this study is independent of p53 binding and degradation, then there are likely to be major differences in the ability of the E6 proteins to contribute to tumorigenicity which are independent of the ability to degrade the p53 protein.
HaCaT-E6 cells, in spite of generating changes in motility, altered levels of integrins and resistance to serum starvation, do not generate foci in soft agar assays (A. Rangarajan and others, unpublished results). However, we have identified a host gene which supports HPV-16 E7 in generating foci in HaCaT-E6 and not in HaCaT cells (A. Rangarajan and others, unpublished results). This is consistent with the view that E6 contributes to transformation in a synergistic manner and is likely to contribute to the overall tumorigenicity of HPV-16-associated lesions. We are currently analysing various HPV-16 E6 mutants to dissect out the contribution of the various regions of the E6 molecule to these phenotypic effects that we report in this study. While there are reports of genes which are specifically turned on as a consequence of E6 expression (Shirasawa et al., 1994 ; Desantes et al., 1992 ; Dey et al., 1997 ; Kinoshita et al., 1997) , given the complexity of the feedback loops with integrins, motility and apoptosis induction, categorically identifying the primary cause and secondary effects will be difficult.
HaCaT cells expressing ras have been shown to induce invasiveness in in vitro assays (Charvat et al., 1998) and induce both invasiveness and angiogenesis in in vivo assays (Skobe et al., 1997) . Needless to say, while the phenotypic effects of E6 reported in this study are intriguing and suggest potential directions to pursue, the broader relevance of this study needs to be evaluated in in vivo studies of cervical tumorigenesis. We have previously reported a switch in the expression of adhesion molecules in the transition from low-to high-grade precursor cervical lesions (Daniel et al., 1997) . This is consistent with the proposed apoptotic and vascular switch in the evolution of precursor lesions (Hanahan & Folkman, 1996) . We are currently evaluating the motility and anti-apoptotic responses of the E6-expressing cell lines and cells obtained from cervical precursor lesions in in vivo assays.
